Literature DB >> 23587917

ERp57/PDIA3 binds specific DNA fragments in a melanoma cell line.

Cristina Aureli1, Elisa Gaucci, Valentina Arcangeli, Caterina Grillo, Margherita Eufemi, Silvia Chichiarelli.   

Abstract

ERp57/PDIA3 is a ubiquitously expressed disulfide isomerase protein, which acts in concert with calreticulin and calnexin in the folding of glycoproteins destined to the plasma membrane or to be secreted. Its canonical compartment is the endoplasmic reticulum, where it acts as a chaperone and redox catalyst, but non canonical locations have been described as well, and ERp57 has been found associated with DNA and nuclear proteins. In previous work performed in HeLa cells, ERp57 has been demonstrated to bind specific DNA sequences involved in the stress response. The direct interaction with the DNA sequences identified as ERp57-targeted regions in HeLa cells has now been confirmed in a melanoma cell line. Furthermore, the ERp57 silencing, achieved by RNA interference, has produced a significant down-regulation of the expression of target genes. The possible involvement of other proteins in complex with ERp57 has been studied by an in vitro biotin-streptavidin based binding assay and the interacting protein APE/Ref-1 has been also assessed for its direct association with the ERp57 target regions. In conclusion, nuclear ERp57 interacts in vivo with DNA fragments in melanoma cells and is potentially involved in the transcriptional regulation of its target genes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23587917     DOI: 10.1016/j.gene.2013.04.004

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

Review 1.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

2.  In oxygen-deprived tumor cells ERp57 provides radioprotection and ensures proliferation via c-Myc, PLK1 and the AKT pathway.

Authors:  Tobias Ocklenburg; Fabian Neumann; Eric Metzen; Ulf Brockmeier; Alexandra Wolf; Julia Vogel; Kirsten Göpelt; Melanie Baumann; Jennifer Baumann; Philip Kranz
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

3.  Proteomic analysis in pterygium; upregulated protein expression of ALDH3A1, PDIA3, and PRDX2.

Authors:  Sun Woong Kim; Jonghoon Lee; Boram Lee; Taiyoun Rhim
Journal:  Mol Vis       Date:  2014-08-27       Impact factor: 2.367

4.  Largescale Transcriptomics Analysis Suggests Over-Expression of BGH3, MMP9 and PDIA3 in Oral Squamous Cell Carcinoma.

Authors:  Yuan He; Fangyang Shao; Weidong Pi; Cong Shi; Yujia Chen; Diping Gong; Bingjie Wang; Zhiwei Cao; Kailin Tang
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

5.  Upregulation of ERp57 promotes clear cell renal cell carcinoma progression by initiating a STAT3/ILF3 feedback loop.

Authors:  Yan Liu; Jian-Xing Wang; Zi-Yuan Nie; Yue Wen; Xin-Ju Jia; Li-Na Zhang; Hui-Jun Duan; Yong-Hong Shi
Journal:  J Exp Clin Cancer Res       Date:  2019-10-30

Review 6.  ERp57/PDIA3: new insight.

Authors:  Silvia Chichiarelli; Fabio Altieri; Giuliano Paglia; Elisabetta Rubini; Marco Minacori; Margherita Eufemi
Journal:  Cell Mol Biol Lett       Date:  2022-02-02       Impact factor: 5.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.